Inactive Instrument
Precision Therapeutics Inc Share Price Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 7.03Cr 6.15Cr 5.67Cr 5.23Cr 9.85Cr 677.34Cr 10Cr 68Cr 27Cr 331.73Cr 26Cr 26Cr 1.14TCr | P/E 2024 |
-0.35x | P/E 2025 | -0.53x |
|---|---|---|---|---|---|
| Enterprise Value | 6.12Cr 5.35Cr 4.94Cr 4.55Cr 8.58Cr 589.47Cr 8.77Cr 59Cr 23Cr 288.7Cr 23Cr 22Cr 993.84Cr | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 121x |
| Free-Float |
93.75% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles L. Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 7.03Cr | ||
| -1.29% | -2.54% | -0.35% | +4.30% | 4.97TCr | ||
| +3.90% | -2.60% | +384.79% | +598.27% | 3.81TCr | ||
| -1.70% | +3.03% | +11.77% | +58.93% | 3.53TCr | ||
| -2.01% | -1.30% | +30.02% | -6.71% | 3.51TCr | ||
| +0.06% | +1.56% | +4.41% | +27.42% | 2.72TCr | ||
| +0.46% | -5.24% | - | - | 1.61TCr | ||
| -0.04% | +0.42% | +70.80% | +121.10% | 1.54TCr | ||
| +1.12% | +2.15% | +16.24% | +19.12% | 1.39TCr | ||
| 0.00% | +0.73% | +18.02% | -30.96% | 1.3TCr | ||
| Average | -0.73% | -0.57% | +66.96% | +98.93% | 2.71TCr | |
| Weighted average by Cap. | -0.15% | -0.64% | +78.08% | +119.96% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 16.24L 14.19L 13.09L 12.07L 22.75L 16Cr 23.25L 1.57Cr 61.56L 7.66Cr 60.98L 59.64L 26Cr | 1L 1L 1L 93.12T 2L 1.21Cr 2L 12.08L 5L 59.09L 5L 5L 2.03Cr |
| Net income | -1.27Cr -1.11Cr -1.02Cr -94.14L -1.77Cr -121.96Cr -1.81Cr -12Cr -4.8Cr -60Cr -4.76Cr -4.65Cr -205.62Cr | -23Cr -20Cr -19Cr -17Cr -33Cr -2.24TCr -33Cr -224.67Cr -88Cr -1.1TCr -88Cr -86Cr -3.78TCr |
| Net Debt | 13.96L 12.2L 11.26L 10.38L 19.56L 13Cr 20L 1.35Cr 52.94L 6.59Cr 52.44L 51.29L 23Cr | -91.25L -79.74L -73.58L -67.82L -1.28Cr -88Cr -1.31Cr -8.79Cr -3.46Cr -43Cr -3.43Cr -3.35Cr -148.15Cr |
Employees
-

















